GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Asset Turnover

Arctic Bioscience AS (OSL:ABS) Asset Turnover : 0.06 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Arctic Bioscience AS's Revenue for the six months ended in Jun. 2024 was kr16.75 Mil. Arctic Bioscience AS's Total Assets for the quarter that ended in Jun. 2024 was kr286.73 Mil. Therefore, Arctic Bioscience AS's Asset Turnover for the quarter that ended in Jun. 2024 was 0.06.

Asset Turnover is linked to ROE % through Du Pont Formula. Arctic Bioscience AS's annualized ROE % for the quarter that ended in Jun. 2024 was -19.05%. It is also linked to ROA % through Du Pont Formula. Arctic Bioscience AS's annualized ROA % for the quarter that ended in Jun. 2024 was -16.40%.


Arctic Bioscience AS Asset Turnover Historical Data

The historical data trend for Arctic Bioscience AS's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS Asset Turnover Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial 0.47 0.23 0.10 0.10 0.11

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.04 0.06 0.06 0.05 0.06

Competitive Comparison of Arctic Bioscience AS's Asset Turnover

For the Biotechnology subindustry, Arctic Bioscience AS's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arctic Bioscience AS's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arctic Bioscience AS's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Arctic Bioscience AS's Asset Turnover falls into.



Arctic Bioscience AS Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Arctic Bioscience AS's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=33.75/( (327.702+300.252)/ 2 )
=33.75/313.977
=0.11

Arctic Bioscience AS's Asset Turnover for the quarter that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=16.746/( (300.252+273.21)/ 2 )
=16.746/286.731
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Arctic Bioscience AS  (OSL:ABS) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Arctic Bioscience AS's annulized ROE % for the quarter that ended in Jun. 2024 is

ROE %**(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=-47.032/246.8255
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-47.032 / 33.492)*(33.492 / 286.731)*(286.731/ 246.8255)
=Net Margin %*Asset Turnover*Equity Multiplier
=-140.43 %*0.1168*1.1617
=ROA %*Equity Multiplier
=-16.40 %*1.1617
=-19.05 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Arctic Bioscience AS's annulized ROA % for the quarter that ended in Jun. 2024 is

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=-47.032/286.731
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-47.032 / 33.492)*(33.492 / 286.731)
=Net Margin %*Asset Turnover
=-140.43 %*0.1168
=-16.40 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Arctic Bioscience AS Asset Turnover Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Arctic Bioscience AS Business Description

Traded in Other Exchanges
N/A
Address
Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand. The company operates in Norway, Europe, Australia and APAC.

Arctic Bioscience AS Headlines

No Headlines